SAN FRANCISCO, CA / ACCESS Newswire / August 5, 2025 / A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), has been filed and seeks to represent investors who purchased or otherwise acquired Replimune (NASDAQ:REPL) securities between November 22, 2024 and July 21, 2025. The lawsuit comes […]
SAN FRANCISCO, CA / ACCESS Newswire / August 5, 2025 / investors in Hims & Hers Health, Inc. (NYSE:HIMS) saw the price of their shares significantly fall during intraday trading on reports that U.S. lawmakers urged the FDA to act against copycat versions of weight loss drugs, citing safety concerns. This latest development follows an
NEW YORK, NY / ACCESS Newswire / August 5, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=159860&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at
HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) — Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced it has received its second U.S. Food and Drug Administration (FDA) 510(k) clearance. The clearance expands the use of its RS001 cardio-respiratory wearable to home environments
NEW YORK CITY, NY / ACCESS Newswire / August 5, 2025 / WHY: New York, N.Y., August 5, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE:CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the "Class Period"), of the important September 8,
Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio(TM) Connected Care Platform GlobeNewswire August 05, 2025 HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) — Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced it has received its second
NEW YORK CITY, NY / ACCESS Newswire / August 5, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ:REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the "Class Period"), of the important September 22, 2025 lead plaintiff deadline in
(NASDAQ:FLYW), NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Flywire Corporation (NASDAQ: FLYW) between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class Period”). A class action
NEW YORK CITY, NY / ACCESS Newswire / August 5, 2025 / WHY: New York, N.Y., August 5, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE:CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the "Class Period"), of the important September 8,
ROSEN, A TOP RANKED LAW FIRM, Encourages Flywire Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLYW GlobeNewswire August 05, 2025 NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of